RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 96 filers reported holding RELMADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $64,380 | -36.5% | 21,460 | -1.6% | 0.01% | -40.9% |
Q1 2024 | $101,454 | +108.7% | 21,818 | +34.6% | 0.02% | +83.3% |
Q3 2023 | $48,618 | +19.7% | 16,206 | -1.8% | 0.01% | +20.0% |
Q2 2023 | $40,605 | +19.7% | 16,506 | +15.3% | 0.01% | +11.1% |
Q1 2023 | $33,931 | – | 14,317 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 2,837,818 | $9,903,985 | 0.42% |
Sio Capital Management, LLC | 235,500 | $821,895 | 0.30% |
Sio Capital Management, LLC | 235,600 | $822,244 | 0.30% |
apricus wealth, LLC | 77,329 | $269,878 | 0.25% |
RTW INVESTMENTS, LP | 2,067,824 | $7,216,706 | 0.15% |
PARSONS CAPITAL MANAGEMENT INC/RI | 496,254 | $1,731,926 | 0.14% |
Aristides Capital LLC | 69,322 | $241,934 | 0.12% |
XTX Topco Ltd | 129,387 | $451,561 | 0.10% |
AdvisorShares Investments LLC | 81,362 | $283,953 | 0.08% |
Ikarian Capital, LLC | 65,491 | $228,563 | 0.06% |